Evidence map›Paper›PMID 36303632›Full record

ArticleFrontiers in reproductive health2022

Practices, Attitudes, and Knowledge Among Healthcare Providers and Oncologists in China Regarding Male Fertility Preservation.

Chuan Huang, Ying Chun Xu, Li Hua Kuang, Qiong Yu Lan, Jing Hu, Wenbing Zhu, Liqing Fan, Qing Li

Open access · goldAbstract read
In one paragraph

Article in Frontiers in reproductive health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. A multidisciplinary evaluation of fertility preservation for oncology patients in Canada The British Columbia perspective.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2025
    Article
  4. Oncologists' current perspective and barriers to men's fertility preservation: a nationwide study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Chuan HuangDepartment of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Ying Chun XuDepartment of Oncology, Renji Hospital of Shanghai Jiaotong University, School of Medicine, Shanghai, China.
Li Hua KuangDepartment of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Qiong Yu LanDepartment of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Jing HuDepartment of Anesthesiology, South Campus, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Wenbing ZhuThe Reproductive & Genetic Hospital of CITIC-XIANGYA, Changsha, China.
Liqing FanThe Reproductive & Genetic Hospital of CITIC-XIANGYA, Changsha, China.
Qing LiDepartment of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Jiangxi Provincial Cancer Hospital · CNReproductive & Genetic Hospital CITIC-Xiangya · CNSecond Affiliated Hospital of Nanchang University · CNRenji Hospital · CNShanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The purpose of this study was to help to promote a better understanding of the male fertility preservation status in China. Methods: In this cross-sectional survey, 1,912 healthcare providers and oncologists were surveyed anonymously using 16 questions carried out at community oncology practices in China from September 2018 to April 2021. 16 questions were designed to evaluate their knowledge on male fertility preservation in cancer patients, assess the factors they considered when deciding whether to discuss male fertility preservation with their patients. Results: Among the 1,912 healthcare providers (42.2% male), 1,713 (89.6%) considered that patients with cancer should be recommended for fertility preservation. 1,264 (66.1%) respondents were aware of male fertility preservation, but only 248 (13.0%) respondents knew the correct institutions. Whether a healthcare provide recommended fertility preservation to their patients depended on the provider's educational background, professional qualifications, hospital grade, area, department, and age. Among the healthcare providers, the three main factors for not recommending fertility preservation for patients with cancer were lack of suitability of the patient for fertility (28.2%), lack of knowledge of fertility preservation (28.6%), and lack of knowledge concerning the institutes that provide fertility preservation (25.4%). Conclusion: Despite this, healthcare providers and oncologists in China showed a positive attitude toward fertility preservation in patients with cancer. Hence, the education of physicians should include fertility preservation, with the aim of increasing their knowledge and awareness. There should be more collaboration between oncologists and reproductive medicine specialists.

Indexed as

attitudesChinahealthcare providermale fertility preservationoncologists

Identifiers

PMID36303632
PMCPMC9580752
OpenAlexW4210683382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.